ResearchBIORXIV2 days ago
Preprint: Seeding patient-derived tau induces tauopathy-specific aggregation and lysosomal disruption in human cells
Scientists created a new laboratory model using brain cells to study how tau proteins clump together in different brain diseases. They used actual tau from patient brains instead of artificial versions, which helps them understand why different diseases cause different types of tau damage. This model also showed how tau clumping breaks down the cell's recycling system, called lysosomes.
WHY IT MATTERSThis research provides a more accurate way to test potential treatments for tauopathies by using real patient tau, which could lead to better drugs that target the specific type of tau damage in individual diseases.